179 related articles for article (PubMed ID: 2568040)
1. [Use of an immunoblotting method for identifying the individual proteins in the antigenic complexes of Bordetella pertussis].
Semina IE; Iankina ZK
Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):78-81. PubMed ID: 2568040
[TBL] [Abstract][Full Text] [Related]
2. [The phenotypic properties of freshly isolated strains of Bordetella].
Lapaeva IA; Milanko AIa; Mebel' SM; Siniashina LN; Ferkel' GIa; Khramova NN; Tepliakova AI; Lomonosova GG; Volgina TI; Shumakov IuL
Zh Mikrobiol Epidemiol Immunobiol; 1991 Mar; (3):13-6. PubMed ID: 1678567
[TBL] [Abstract][Full Text] [Related]
3. [Physicochemical and biological characteristics of preparations of an antigenic complex isolated from the cultivation medium of Bordetella pertussis].
Semina IE; Bazhanova IG; Tsvetkova NV; Remova TN; Ozeretskovskaia MN
Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):76-9. PubMed ID: 2904201
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae.
Cowell JL; Zhang JM; Urisu A; Suzuki A; Steven AC; Liu T; Liu TY; Manclark CR
Infect Immun; 1987 Apr; 55(4):916-22. PubMed ID: 2881893
[TBL] [Abstract][Full Text] [Related]
5. [A comparative analysis of the antigenic complexes isolated from synthetic and semisynthetic media for the cultivation of Bordetella pertussis].
Semina IE; Bazhanova IG; Melikhov VI; Chechot VA; Mileĭkovskaia MM; Mertsalova NU; Shmeleva EI; Remova TN; Sukhinova EE; Ozeretskovskaia MN
Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):87-92. PubMed ID: 7653146
[TBL] [Abstract][Full Text] [Related]
6. [Immunobiologic activity of Bordetella pertussis strains defective in various virulence factors].
Smirnov VD; Chuprinina RP; Siundiukova RA; Maksiutov RV
Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):8-10. PubMed ID: 2545060
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
[TBL] [Abstract][Full Text] [Related]
8. Fimbrial hemagglutinin in stationary and shake cultures of Bordetella pertussis.
Arai H; Munoz JJ
Infect Immun; 1979 Aug; 25(2):764-7. PubMed ID: 39897
[TBL] [Abstract][Full Text] [Related]
9. Quantification of pertussis toxin, filamentous haemagglutinin, 69 kDa outer membrane protein, agglutinogens 2 and 3 and lipopolysaccharide in the Danish whole-cell pertussis vaccine.
Ibsen PH; Petersen JW; Heron I
Vaccine; 1993; 11(3):318-22. PubMed ID: 8447160
[TBL] [Abstract][Full Text] [Related]
10. Protection against intranasal infection of mice with Bordetella pertussis.
Robinson A; Ashworth LA; Baskerville A; Irons LI
Dev Biol Stand; 1985; 61():165-72. PubMed ID: 2872102
[TBL] [Abstract][Full Text] [Related]
11. Purification and crystallization of fimbrial hemagglutinin from Bordetella pertussis.
Arai H; Munoz JJ
Infect Immun; 1979 Jul; 25(1):460-2. PubMed ID: 39033
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of Bordetella pertussis toxin and filamentous haemagglutinin concentrations by hydroxyapatite high-performance liquid chromatography.
Chong P; Jackson G; Cwyk W; Klein M
J Chromatogr; 1990 Jul; 512():227-36. PubMed ID: 2172264
[TBL] [Abstract][Full Text] [Related]
13. Separation and purification of the hemagglutinins from Bordetella pertussis.
Sato Y; Cowell JL; Sato H; Burstyn DG; Manclark CR
Infect Immun; 1983 Jul; 41(1):313-20. PubMed ID: 6305841
[TBL] [Abstract][Full Text] [Related]
14. Immunoelectron microscopy of antigens of Bordetella pertussis using monoclonal antibodies to agglutinogens 2 and 3, filamentous haemagglutinin, pertussis toxin, pertactin and adenylate cyclase toxin.
Blom J; Heron I; Hendley JO
APMIS; 1994 Sep; 102(9):681-9. PubMed ID: 7946271
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of fimbriae isolated from Bordetella pertussis.
Zhang JM; Cowell JL; Steven AC; Carter PH; McGrath PP; Manclark CR
Infect Immun; 1985 May; 48(2):422-7. PubMed ID: 2859248
[TBL] [Abstract][Full Text] [Related]
16. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen.
Zhang JM; Cowell JL; Steven AC; Manclark CR
Dev Biol Stand; 1985; 61():173-85. PubMed ID: 2872103
[TBL] [Abstract][Full Text] [Related]
17. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
Thomas MG; Ashworth LA; Miller E; Lambert HP
J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
[TBL] [Abstract][Full Text] [Related]
18. Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis.
Ashworth LA; Irons LI; Dowsett AB
Infect Immun; 1982 Sep; 37(3):1278-81. PubMed ID: 6127315
[TBL] [Abstract][Full Text] [Related]
19. [A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine].
Zakharova NS; Shmeleva EI; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Mertsalova NU; Britsina MV; Ermolova EV; Zaĭtsev EM
Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):70-2. PubMed ID: 9304336
[TBL] [Abstract][Full Text] [Related]
20. [Importance of immunoelectrophoresis in agar and disc electrophoresis in polyacrylamide gel for characterizing different strains of Bordetella pertussis].
Samsonova VS; Mamaeva EA; Bakulina NA; Efimova OG; Bevz NI
Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):47-50. PubMed ID: 6308926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
